Edwards Lifesciences
Apple’s possibility to challenge USPTO’s rule
The decision of the Appeal Court of 13 March 2023 rekindled the challenge of Apple & other big techs to the U.S. patent-review procedure.
Ad Astra Per Aspera
The decision of the Appeal Court of 13 March 2023 rekindled the challenge of Apple & other big techs to the U.S. patent-review procedure.